Comorbidity in Multiple Sclerosis
نویسندگان
چکیده
منابع مشابه
Comorbidity in US patients with multiple sclerosis
Objective To assess the trends in the prevalence of comorbidities in US patients with multiple sclerosis (MS), and the association of demographic characteristics with the presence of comorbidities. Study design A retrospective analysis was conducted from a sample of 5 million patients from the IMS Health Real World Data Adjudicated Claims - US database. Methods Comorbidity in patients with ...
متن کاملJournal Club: Effect of comorbidity on mortality in multiple sclerosis.
Multiple sclerosis (MS) is a chronic demyelinating disease of the CNS estimated to reduce life expectancy by 7–14 years compared to demographically similar groups in the general population. While several disease complications pose a potential risk for mortality, results from large observational studies suggest that comorbidities substantially influence survival in MS. In a recent Neurology® art...
متن کاملEffect of comorbidity on mortality in multiple sclerosis
OBJECTIVE We aimed to compare survival in the multiple sclerosis (MS) population with a matched cohort from the general population, and to evaluate the association of comorbidity with survival in both populations. METHODS Using population-based administrative data, we identified 5,797 persons with MS and 28,807 controls matched on sex, year of birth, and region. We estimated annual mortality ...
متن کاملThe challenge of comorbidity in clinical trials for multiple sclerosis.
OBJECTIVE We aimed to provide recommendations for addressing comorbidity in clinical trial design and conduct in multiple sclerosis (MS). METHODS We held an international workshop, informed by a systematic review of the incidence and prevalence of comorbidity in MS and an international survey about research priorities for studying comorbidity including their relation to clinical trials in MS....
متن کاملRecommendations for observational studies of comorbidity in multiple sclerosis.
OBJECTIVE To reach consensus about the most relevant comorbidities to study in multiple sclerosis (MS) with respect to incidence, prevalence, and effect on outcomes; review datasets that may support studies of comorbidity in MS; and identify MS outcomes that should be prioritized in such studies. METHODS We held an international workshop to meet these objectives, informed by a systematic revi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of MS Care
سال: 2016
ISSN: 1537-2073
DOI: 10.7224/1537-2073.2016-086